Literature DB >> 22497466

QSAR and QSPR model interpretation using partial least squares (PLS) analysis.

David T Stanton1.   

Abstract

Carefully developed quantitative structure-activity and structure-property relationship models contain detailed information regarding how differences in the molecular structure of compounds correlate with differences in the observed biological or other physicochemical properties of those compounds. The ability to understand the behavior of existing molecules and to design new molecules is facilitated by using an objective method to extract and explain the details of the underlying structure-activity or structure-property relationship. Furthermore, a clear understanding of how and why compounds behave as they do can lead to new innovations through model-directed selection of compounds to be used in complex mixtures such as laundry detergents, fabric softeners, and shampoos. Such a method has been developed based on partial least-squares (PLS) regression analysis that allows for the identification of specific structural trends that relate to differences in observed properties. But the analysis of the completed model is only the last step of the process. The model development process itself affects the ability to extract a clear interpretation of the model. Everything from the selection of initial pool of molecular descriptors to evaluate to data set and model optimization impacts the ability to derive detailed molecular design information. This review describes the method details and examples of the use of PLS for model interpretation and also outlines suggestions regarding model development and model and data set optimization that enable the interpretation process.

Mesh:

Year:  2012        PMID: 22497466     DOI: 10.2174/157340912800492357

Source DB:  PubMed          Journal:  Curr Comput Aided Drug Des        ISSN: 1573-4099            Impact factor:   1.606


  17 in total

1.  3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.

Authors:  Prathusha Kakarla; Madhuri Inupakutika; Amith R Devireddy; Shravan Kumar Gunda; Thomas Mark Willmon; K C Ranjana; Ugina Shrestha; Indrika Ranaweera; Alberto J Hernandez; Sharla Barr; Manuel F Varela
Journal:  Int J Pharm Sci Res       Date:  2016-02-01

2.  Alarms about structural alerts.

Authors:  Vinicius Alves; Eugene Muratov; Stephen Capuzzi; Regina Politi; Yen Low; Rodolpho Braga; Alexey V Zakharov; Alexander Sedykh; Elena Mokshyna; Sherif Farag; Carolina Andrade; Victor Kuz'min; Denis Fourches; Alexander Tropsha
Journal:  Green Chem       Date:  2016-06-28       Impact factor: 10.182

3.  Biomacromolecular quantitative structure-activity relationship (BioQSAR): a proof-of-concept study on the modeling, prediction and interpretation of protein-protein binding affinity.

Authors:  Peng Zhou; Congcong Wang; Feifei Tian; Yanrong Ren; Chao Yang; Jian Huang
Journal:  J Comput Aided Mol Des       Date:  2013-01-10       Impact factor: 3.686

4.  Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding model.

Authors:  Jian-Hua Ran; Min Li; Weng-Ieong Tou; Tian-Luo Lei; Hong Zhou; Calvin Yu-Chian Chen; Bao-Xue Yang
Journal:  Acta Pharmacol Sin       Date:  2016-05-30       Impact factor: 6.150

5.  Informatics Approaches for Predicting, Understanding, and Testing Cancer Drug Combinations.

Authors:  Jing Tang
Journal:  Methods Mol Biol       Date:  2017

6.  Developing hypothetical inhibition mechanism of novel urea transporter B inhibitor.

Authors:  Min Li; Weng Ieong Tou; Hong Zhou; Fei Li; Huiwen Ren; Calvin Yu-Chian Chen; Baoxue Yang
Journal:  Sci Rep       Date:  2014-07-22       Impact factor: 4.379

7.  Proline-Based Carbamates as Cholinesterase Inhibitors.

Authors:  Hana Pizova; Marketa Havelkova; Sarka Stepankova; Andrzej Bak; Tereza Kauerova; Violetta Kozik; Michal Oravec; Ales Imramovsky; Peter Kollar; Pavel Bobal; Josef Jampilek
Journal:  Molecules       Date:  2017-11-14       Impact factor: 4.411

8.  Drug design for neuropathic pain regulation from traditional Chinese medicine.

Authors:  Weng Ieong Tou; Su-Sen Chang; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Sci Rep       Date:  2013-01-30       Impact factor: 4.379

9.  A combination of 3D-QSAR, molecular docking and molecular dynamics simulation studies of benzimidazole-quinolinone derivatives as iNOS inhibitors.

Authors:  Hao Zhang; Jinhang Zan; Guangyun Yu; Ming Jiang; Peixun Liu
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

10.  Towards Intelligent Drug Design System: Application of Artificial Dipeptide Receptor Library in QSAR-Oriented Studies.

Authors:  Andrzej Bak; Violetta Kozik; Malgorzata Walczak; Justyna Fraczyk; Zbigniew Kaminski; Beata Kolesinska; Adam Smolinski; Josef Jampilek
Journal:  Molecules       Date:  2018-08-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.